Drug profile · INN
butorphanol tartrate
BUTORPHANOL TARTRATE
butorphanol tartrate (BUTORPHANOL TARTRATE) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — butorphanol tartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
butorphanol tartrate (BUTORPHANOL TARTRATE) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Kappa opioid receptor partial agonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is butorphanol tartrate?
butorphanol tartrate (BUTORPHANOL TARTRATE) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for butorphanol tartrate?
BUTORPHANOL TARTRATE is a marketed brand name for butorphanol tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of butorphanol tartrate?
butorphanol tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.